Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:28:21.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added New York as a study location under Locations and updated the page to revision v3.3.3. The previous 'New York Locations' entry and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T22:32:17.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The revision label updated from v3.2.0 to v3.3.2. No study-related content appears to be altered.
    Difference
    0.1%
    Check dated 2025-11-25T11:26:21.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The government funding notice about potential delays and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:12:19.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Two screenshots show the same study page with no significant additions or deletions; any visible differences are minor formatting changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:18:27.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    - Version updated from v3.1.0 to v3.2.0. - Added a prominent notice about government funding lapse and potential delays, and directing users to operating-status resources (cc.nih.gov, opm.gov).
    Difference
    3%
    Check dated 2025-10-06T06:39:09.000Z thumbnail image

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.